Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

TAVI May Improve Cognitive Function in Patients with Prior Deterioration

Cognitive Function TAVIThis work studies cognitive evolution after transcatheter aortic valve implantation (TAVI). Previous smaller studies reported conflicting results on cognitive function after TAVI.

 

This study prospectively included 229 patients who were ≥70 years old, had undergone TAVI and were assessed using the Mini Mental State Examination before and 6 months after the procedure. Cognitive deterioration or improvement was defined as a decrease or increase in the Mini Mental State Examination score of at least 3 points between baseline and 6 months.

 

Cognitive deterioration was found in 29 patients (12.7%), although no statistically significant predictor of this event was identified. However, observation of the 8 patients with the highest deterioration score (Mini Mental State Examination score decrease of ≥5 points) revealed possible specific causes, such as postinterventional delirium, postinterventional stroke, progressive renal failure, progressive heart failure, or preexisting cerebrovascular disease.

 

There were 48 patients with baseline cognitive deterioration (Mini Mental State Examination score <26 points), of whom 18 (37.5%) improved significantly.

 

The preinterventional aortic valve area was lower in patients who cognitively improved after the procedure (mean baseline aortic valve area 0.6 cm²) when compared with patients whose score remained similar to their baseline score (mean baseline aortic valve area 0.7 cm²; p = 0.01).

 

Conclusion

This is the first study providing evidence that transcatheter aortic valve replacement may result in cognitive improvement among patients who had preprocedural cognitive impairment, which may be possibly related to hemodynamic improvement. This study also confirms that some patients experience cognitive deterioration after the procedure.

 

Original title: Evolution of Cognitive Function After Transcatheter Aortic Valve Implantation.

Reference: Andreas W. Schoenenberger et al. Circ Cardiovasc Interv. 2016 Oct;9(10).

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI

With the expansion of TAVI to younger and lower surgical risk patients, bioprosthetic valve degeneration and the need for repeat interventions are expected to...

Percutaneous Closure of Patent Foramen Ovale in Patients Over 60 Years Old With Cryptogenic Stroke: A Safe and Effective Strategy?

Cryptogenic stroke accounts for up to one-third of all ischemic strokes and remains strongly associated with the presence of a patent foramen ovale (PFO),...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...